Table 15.
Organs | Observations | Dose groups (mg/kg bw/day) | |||||
---|---|---|---|---|---|---|---|
Control | 100 | 360 | 720 | ||||
Main | Recovery | Main | Recovery | ||||
Male | |||||||
Adrenal gland | Increased cytoplasmic vacuolation | 0/10 | 0/5 | 0/10 | 0/10 | 6/10 | 0/5 |
Kidney | Cyst | 1/10 | 0/5 | 0/1 | / | 0/10 | 0/5 |
Mineral deposits | 0/10 | 0/5 | 1/1 | / | 0/10 | 0/5 | |
Lungs | Alveolar emphysema | 0/10 | 0/5 | / | / | 1/10 | 1/5 |
Alveolar histiocytosis | 2/10 | 0/5 | / | / | 1/10 | 0/5 | |
| |||||||
Female | |||||||
Adrenal gland | Increased cytoplasmic vacuolation | 0/10 | 0/5 | 0/10 | 0/10 | 8/10 | 0/5 |
Kidneys | Focal fibrosis | 0/10 | 0/5 | 1/1 | 0/1 | 0/10 | 0/5 |
Lungs | Alveolar emphysema | 1/10 | 0/5 | / | / | 0/10 | 1/5 |
Acute hemorrhage | 0/10 | 1/5 | / | / | 0/10 | 0/5 | |
Alveolar histiocytosis | 1/10 | 0/5 | / | / | 3/10 | 0/5 | |
Uterus | Dilatation | 4/10 | 3/5 | / | / | 2/10 | 1/5 |
/, not examined.
Data represent the number of animals with observation per number of animals observed.